On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series A – Versanis Bio
On Aug 31, 2021 Versanis Bio closed a Series A round and raised $70,000,000 from Aditum Bio, Atlas Venture, Medicxi Ventures, featuring lead investors Atlas […]
Series C – TISSIUM
On Aug 31, 2021 TISSIUM closed a Series C round and raised €50,000,000 from Cathay Capital, Sofinnova Partners, featuring lead investors Cathay Capital. About the […]
Series C – Oviva
On Aug 31, 2021 Oviva closed a Series C round and raised €67,000,000 from AlbionVC, Earlybird Venture Capital, Eight Roads Ventures, F-Prime Capital, MTIP AG, […]
Venture Round – Apexian Pharmaceuticals
On Aug 31, 2021 Apexian Pharmaceuticals closed a Venture – Series Unknown round and raised $100,000 from IU Ventures, featuring lead investors IU Ventures. About […]
Series A – Wellbe
On Aug 31, 2021 Wellbe closed a Series A round and raised $2,000,000 from HealthX Ventures, WISC Partners, featuring lead investors HealthX Ventures. About the […]
Series A – Osana Salud
On Aug 31, 2021 Osana Salud closed a Series A round and raised $20,000,000 from Coelius Capital, General Catalyst, featuring lead investors General Catalyst. About […]
Seed Round – Affect Therapeutics
On Aug 31, 2021 Affect Therapeutics closed a Seed round and raised $6,000,000 from Acumen, AlleyCorp, City Light Capital, Kapor Capital, featuring lead investors . […]
Series C – Alma
On Aug 31, 2021 Alma closed a Series C round and raised $50,000,000 from Insight Partners, featuring lead investors . About the company: Alma is […]
Series B – quip
On Aug 31, 2021 quip closed a Series B round and raised $100,000,000 from Cowen Group, featuring lead investors Cowen Group. About the company: quip […]
